| (AUD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 5.28M | 81.44% |
| Operating expense | — | — |
| Net income | -7.93M | -38.90% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ATH.AX returned -15.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +26.2% |
| 1 year | -15.8% |
| 5 years | -69.4% |
| 10 years | -90.8% |
| All-time high | $107.50 (Sep 2002) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ATH.AX would be worth today ›No. Alterity Therapeutics Limited has not paid a dividend in the past 12 months.
Alterity Therapeutics Limited is part of the Healthcare sector.
Alterity Therapeutics Limited has a market cap of 109.84M AUD, based on the latest quote.
